OSAM
VYGR icon

O'Shaughnessy Asset Management’s Voyager Therapeutics VYGR Stock Holding History

O'Shaughnessy Asset Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-17,352
Closed -$137K – 2197
2024
Q2 		$137K Sell
17,352
-4,497
-21% -$37.7K ﹤0.01% 1610
2024
Q1 		$203K Sell
21,849
-6,016
-22% -$50.8K ﹤0.01% 1500
2023
Q4 		$235K Sell
27,865
-23,825
-46% -$173K ﹤0.01% 1327
2023
Q3 		$401K Buy
51,690
+29,331
+131% +$268K 0.01% 1005
2023
Q2 		$256K Buy
+22,359
New +$231K ﹤0.01% 1109

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

O'Shaughnessy Asset Management's VYGR Position: Q3 2024 in Review

O'Shaughnessy Asset Management sold out of Voyager Therapeutics (VYGR) in Q3 2024, closing a stake of 17,352 shares — an estimated $137K sold.

O'Shaughnessy Asset Management first reported a position in VYGR in Q2 2023 and held it in 5 quarters. The position peaked at $401K in Q3 2023. 128 funds tracked by Wall St. Rank hold VYGR as of Q3 2024.

  • O'Shaughnessy Asset Management reported no remaining Voyager Therapeutics position as of Q3 2024 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 17,352 Voyager Therapeutics shares in Q3 2024, an estimated $137K.
  • O'Shaughnessy Asset Management first reported a position in Voyager Therapeutics in Q2 2023 and held it in 5 quarters.
  • O'Shaughnessy Asset Management's Voyager Therapeutics position peaked at $401K in Q3 2023.
  • 128 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2024.

Based on O'Shaughnessy Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.